Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroSCORE Marzia.

Slides:

Advertisements

Similar presentations

The “occasional open heart surgeon” revisited

Advertisements

Previous coronary stents do not increase early and long-term adverse outcomes in patients undergoing off-pump coronary artery bypass grafting: A propensity-matched.

Total arterial revascularization of triple vessel coronary disease based on combined internal thoracic and radial artery grafts Robert H. Habib, PhD,

Manuel J. Antunes, MD, PhD, DSc

Cyrus J. Parsa, MD, Linda K. Shaw, MS, J. Scott Rankin, MD, Mani A

The impact of placing multiple grafts to each myocardial territory on long-term survival after coronary artery bypass grafting Danny Chu, MD, Faisal.

Trends in isolated coronary artery bypass grafting: An analysis of the Society of Thoracic Surgeons adult cardiac surgery database Andrew W. ElBardissi,

The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy John W.C.

Standardizing definitions for hybrid coronary revascularization

The impact of incomplete revascularization and angiographic patency on midterm results after off-pump coronary artery bypass grafting Jota Nakano, MD,

The present day potential role of fractional flow reserve–guided coronary artery bypass graft surgery Filip Casselman, MD, PhD, FETCS, Johan Van der.

James P. Greelish, MD, Marzia Leacche, MD, Natalia S

Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies Hisato Takagi,

Peter K. Smith, MD The Journal of Thoracic and Cardiovascular Surgery

The impact of a second arterial graft on 5-year outcomes after coronary artery bypass grafting in the Synergy Between Percutaneous Coronary Intervention.

Right internal thoracic artery or saphenous vein grafting

Intrinsic cardiac stem cells are essential for regeneration

Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: An updated meta-analysis.

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Defining operative mortality: Impact on outcome reporting

Why surgery won the SYNTAX trial and why it matters

Zhe Zheng, MD, PhD, Heng Zhang, MD, PhD, Bo Xu, MBBS

Coronary artery bypass in patients with type 2 diabetes: Experience from the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial Edward.

Silvana Molossi, MD, PhD, Carlos M. Mery, MD, MPH

Multilevel data analysis: What? Why? How?

Harold L. Lazar, MD The Journal of Thoracic and Cardiovascular Surgery

Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris Toshihiro Fukui,

The lord of the rings Antonio Miceli, MD, PhD

Igor E. Konstantinov, MD, PhD, FRACS

Surgical economics: MACRA, MIPS, and bundles—Lessons learned in the first 3 years of a coronary artery bypass grafting alternative payment model Daniel.

Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Takuya Umemoto, MD, PhD

The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation David.

Performance of the European System for Cardiac Operative Risk Evaluation II: A meta- analysis of 22 studies involving 145,592 cardiac surgery procedures

Michael Mack, MD, David Taggart, MD

Open aortic arch reconstruction after previous cardiac surgery: Outcomes of 168 consecutive operations Eduard Quintana, MD, FETCS, Pietro Bajona, MD,

Innovation and science: The future of valve design

Oh, father, where art we? Left internal mammary artery with greater saphenous vein grafts still rules surgical coronary revascularization after 30 years

It's not “just a shunt” but sometimes it should be…

For everything there is a season

A first start for lung transplantation?

Right ventricular failure after cardiac surgery: Why can't right ventricular assist device support fix the problem? Francis D. Pagani, MD, PhD The Journal.

To bypass or stent? The changing rules of an advancing game

Management of new-onset mitral regurgitation with intraoperative angiography and intraoperative percutaneous coronary intervention James P. Greelish,

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass Benjamin Medalion, MD, Michael G. Katz, MD,

Derrick Y. Tam, MD, Stephen E. Fremes, MD, MSc

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

Attachment disorder in thoracoabdominal surgery

Influence of experience and the surgical learning curve on long-term patient outcomes in cardiac surgery Bryan M. Burt, MD, Andrew W. ElBardissi, MD,

Shengshou Hu, MD, Xin Yuan, MD, PhD

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

The thoracoabdominal saga and heroes

Left ventricular assist device implantation after acute anterior wall myocardial infarction and cardiogenic shock: A two-center study Nicholas C. Dang,

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Effect of one-stop hybrid coronary revascularization on postoperative renal function and bleeding: A comparison study with off-pump coronary artery bypass.

Benefits of ambulatory axillary intra-aortic balloon pump for circulatory support as bridge to heart transplant Ramanan Umakanthan, MD, Steven J. Hoff,

The future of cardiac surgery training: A survival guide

Improved quality and cost-effectiveness of coronary artery bypass grafting in the United States from 1988 to 2005 Howard K. Song, MD, PhD, Brian S. Diggs,

“The more things change…”: The challenges ahead

Commentary: Judgment day: Should you add atrial fibrillation ablation?

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

First in line for robotic surgery: Would you want to know?

Apples remain apples NO matter what

A large international single-center case-series of coronary artery fistulas in children: When high clinical research standards adopted globally create.

The Clinical Significance and Management Implications of Chronic Total Occlusion Associated With Surgical Coronary Artery Revascularization Lorenzo Azzalini,

Preoperative PFTs: The answer is blowing in the wind

Commentary: Evaluation of primary graft dysfunction after lung transplantation—It is time to teach an old dog new tricks! W. Hampton Gray, MD, P. Michael.

IS local wound infection rate more important than long-term graft patency in coronary artery bypass grafting? Tomislav Kopjar, MD, PhD, Michael R. Dashwood,

Presentation transcript:

Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroSCORE Marzia Leacche, MD, John G. Byrne, MD, Natalia S. Solenkova, MD, PhD, Brendan Reagan, MD, Tahir I. Mohamed, MD, PhD, Joseph L. Fredi, MD, David X. Zhao, MD The Journal of Thoracic and Cardiovascular Surgery Volume 145, Issue 4, Pages 1004-1012 (April 2013) DOI: 10.1016/j.jtcvs.2012.03.062 Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 The 30-day composite cardiac and cerebrovascular outcomes in the coronary artery bypass grafting (CABG) group and hybrid coronary revascularization (HCR) stratified by Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) and European System for Cardiac Operative Risk Evaluation (euroSCORE). The Journal of Thoracic and Cardiovascular Surgery 2013 145, 1004-1012DOI: (10.1016/j.jtcvs.2012.03.062) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions